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Testicular germ cell tumors (GCT) are the commonest solid tumors in young men. Typical presentation is with painless scrotal
swelling; however, symptoms related to complications or metastasis may be the initial presentation. Gastrointestinal (GI) metastasis
is seen in about 5% of patients with germ cell tumors and presentation is commonly with GI bleed. It is important to have GCT as
a differential diagnosis of GI bleed in young men presenting with unexplained anemia as direct questioning about scrotal swelling
and genital examination when appropriate will guide further investigation and facilitate prompt diagnosis. We present a case of
a 26-year-old man with testicular germ cell tumor and severe anemia secondary to extension and perforation of duodenum by
retroperitoneal metastasis and a review of the literature on the gastrointestinal manifestations of testicular germ cell tumors.

1. Introduction
Testicular germ cell tumors (GCT) make up 95% of testicular cancers and are the commonest solid malignancies
in young men [1]. Classic presentation is as a painless
testicular swelling; however, in 10% of patients, presentation
is variable and related to site of metastasis and complications.
Gastrointestinal (GI) metastasis is seen in 5% of germ
cell tumors and rare presentation with hemodynamically
significant gastrointestinal bleed or as occult bleed have been
reported [2, 3].

2. Case Report
A 26-year-old previously healthy man presented to the emergency department (ED) after an outpatient computed tomography (CT) of the chest showed large burden pulmonary
embolus and a 13 mm left lower lobe nodule. He had previously presented at his primary care physician’s office with
complaints of low back pain, shortness of breath, chest pain,

and bilateral leg swelling that had prompted the imaging. The
patient reported severe low back pain for 2 weeks with limitation of movement due to pain prior to onset of shortness
of breath, chest pain, and bilateral leg swelling. There was
no associated cough or hemoptysis. History was otherwise
unremarkable including no prior history of personal or
family history of cancers or thrombotic conditions, recent
surgery, or trauma. He had a 6-pack-year history of tobacco
use.
On presentation in the ED, vital signs were significant for
tachycardia (pulse rate of 107 beats/minutes), blood pressure
of 121/62 mmHg, temperature of 36.9∘ C, and 99% oxygen
saturation on room air.
Physical examination revealed a pale patient with bilateral
lower extremity edema without tenderness or erythema.
Other examinations including abdominal examination were
unremarkable; testicular examination was not documented.
Laboratory data showed significant anemia with hemoglobin of 5.6 g/dl (normal: 14.0–17.5 g/dl; last known hemoglobin from 9 years earlier was 15.7 g/dl), white blood
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Figure 1: Ulcerated friable duodenal mass noted on esophagogastroduodenoscopy.

count of 6200/𝜇L (normal: 4800–10800/𝜇L), platelet count
264,000/𝜇L (normal: 130,000–400,000 𝜇L), mean corpuscular volume 82.7 fL (normal: 80.0–99.9 fL), and mean corpuscular hemoglobin 27.5 pg (normal: 27–34 pg). Iron studies
were consistent with iron deficiency anemia with ferritin
of 18 ng/ml (normal: 27–300 ng/ml), iron of <10 mcg/dL
(normal: 50–212 mcg/dL), iron saturation < 3% (normal:
20–50%), and high normal TIBC of 390 ug/dL (normal:
250–425 ug/dL). Electrolytes and hepatic function were
within normal limits. Troponin was negative and BNP was
27 pg/ml (0–100 pg/ml). Patient admitted to taking Ibuprofen
400 mg twice a day for back pain for 2 weeks but denied
hematochezia, melena, or bleeding from any site. He declined
a digital rectal examination.
Esophagogastroduodenoscopy (EGD) to further investigate his anemia revealed an ulcerated, friable mass within
the mid second to third portion of the duodenum (Figure 1).
Multiple biopsies were taken with a recommendation for
further work-up for duodenal mass.
A CT scan of abdomen and pelvis found a large soft
tissue density mass-like structure in the right retroperitoneal
space measuring up to 13.4 cm × 9.2 cm extending into the
second and third portion of the duodenum with a contained
perforation of the duodenum. In addition, a 3.4 × 2.7 cm
enlarged para-aortic lymph node and thrombosis of the IVC
extending to the right renal vein was also noted. Magnetic
resonance imaging of the brain was normal.
Given findings on EGD and CT scan, additional history
was obtained which revealed a history of testicular trauma
many years priorly when he was hit by a baseball in the right
testicle with persistent scrotal swelling; however, the swelling
had progressively worsened in the past 1 year. Testicular exam
showed a firm right scrotal swelling, twice the size of the
left testicle. Scrotal ultrasound revealed 4 separate masses. BHCG was elevated to 1468 mIU/mL (normal 0–4 mIU/mL),
LDH was 367 IU/L (normal 140–271 IU/L), and alpha fetoprotein (AFP) was normal (0.9 ng/mL).
Histopathology of the duodenal mass showed a poorly
differentiated malignant neoplasm strongly positive for placenta alkaline phosphatase (PLAP), consistent with a malignant germ cell tumor (Figures 2–4).
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Figure 2: Duodenal mass, metastatic seminoma (H&E stain, magnification ×40).

Figure 3: Duodenal mass, metastatic seminoma (H&E stain, magnification ×400).

Figure 4: Duodenal mass with metastatic seminoma (PLAP IHC
stain, magnification ×200).

He underwent a right radical orchiectomy. Gross examination of the right testis revealed four distinct tumor nodules
in the testis (Figure 5).
Two of the nodules showed reactivity for beta-HCG.
Sporadic CK7 immunoreactivity was seen in the nodules
expressing beta-HCG. All four nodules showed immunoreactivity for PLAP (Figure 6).
The pathologic findings were consistent with a seminoma.
He was staged as Stage IIIA, pT1N3M1aS1 given the metastases to the retroperitoneum and lungs.
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Figure 5: Gross right testis, bisected, showing nodules within the
testis.

Figure 6: Testicular seminoma (PLAP IHC stain, magnification
×40).

Lower extremity Doppler was negative for DVT. Given
burden of blood clot and severe anemia with occult gastrointestinal bleed, an inferior vena cava (IVC) filter was urgently
placed. During IVC placement, occlusion of the infrarenal
IVC with filling defects extending into the right renal vein was
noted. He was subsequently started on anticoagulant given
extensive clot burden and underlying malignancy.
He initially received standard chemotherapy with bleomycin, etoposide, and cisplatin, but bleomycin was discontinued after the first cycle when surveillance PFT showed diffusion abnormalities. Patient completed 4 cycles of chemotherapy (etoposide and cisplatin). Imaging following completion
of chemotherapy showed complete resolution of lung nodule
but greater than 3 cm residual retroperitoneal mass with
undetectable HCG, but LDH remained elevated at 314 IU/L.
Patient is scheduled for a 6-week follow-up PET scan per
NCCN clinical guidelines.

3. Discussion
Our patient presented primarily with shortness of breath
related to pulmonary embolism and severe anemia. Additionally, extensive thrombosis with bilateral pulmonary
embolism, inferior vena cava (IVC), and right renal vein
thrombosis were also found. This patient’s symptoms related
to metastasis included debilitating back pain from retroperitoneal metastasis with extension and perforation of the
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duodenum, likely resulting in gastrointestinal bleeding and
severe anemia. Interestingly, our patient did not report
hematochezia or melena.
GI manifestation of GCT is uncommon (5%) with duodenal involvement seen in 1.4% of cases [2]. Gastrointestinal
bleeding from site of metastasis following chemotherapy
has also been reported [4–6]. Mechanisms include GI perforation following chemotherapy-induced tumor necrosis
and shrinking of metastatic gastrointestinal tumor following
chemotherapy [7]. Other chemotherapy-related complications involving the GI tract include cases of neutropenic colitis following salvage therapy for refractory nonseminomatous
GCT of the testis [8, 9].
There is also an increased risk of stomach cancer following radiotherapy among survivors [10–12]. Overall, gastrointestinal second cancers were higher in seminomas compared
to nonseminomas in a review of 5533 survivors in Swedish
cancer database [13]. Gastrointestinal symptoms can also be
the first symptom of recurrence in patients with previously
treated GCT. GCT presenting as abdominal pain with finding
of polypoid masses in the gastrointestinal tract within 2 years
of orchiectomy and chemotherapy have been reported [14,
15].
Because gastrointestinal presentations of GCT are unusual, they are often not suspected on presentation. A
complete physical examination including a scrotal exam may
provide the initial clues as to the potential etiology and should
not be overlooked, especially since testicular cancers are generally quite curable [16]. Of the estimated 8720 new testicular
cancer diagnoses of 2016, less than 400 deaths were anticipated [1]. However, correctly classifying patient and accurate
diagnosis play a vital role in achieving good outcomes.
There have been reports of “burnt-out” testicular cancer
with presentation related to sites of metastasis in the absence
of testicular findings on physical examination or ultrasound. Stokes and Perkins reported a 22-year-old male with
metastatic testicular choriocarcinoma with metastasis to the
stomach, lungs, liver, kidney, and brain, however, with grossly
normal testis with autopsy findings of foci area of scarring
and calcification within the testis [17]. Similarly, Altamar et al.
reported a 20-year-old with metastatic testicular seminoma
with pure seminoma of right testis and concurrent embryonal
carcinoma in duodenal mass. A finding of 0.6 cm focus
of scarring with calcification likely representing burnt-out
primary embryonal tumor versus differentiation at the site of
metastasis was a possible explanation [18]. Balogun-Ojuri et
al. reported a case of possible primary seminoma of the small
bowel with mesenteric nodal involvement. A primary small
bowel seminoma was made given normal AFP, normal HCG,
and ultrasonographically normal testis. The patient however
had a history of undescended testis with orchidopexy and
the possibility of jejunal metastasis from an occult primary
testicular lesion was entertained [19]. These findings are
important as these patients are more likely to present with
metastatic symptoms including GI symptoms than testicular
mass or swelling.
In a review of patients with GCT with GI symptoms at
first presentation, we found 24 publications totaling 25 patients (see Supplementary Table 1 in Supplementary Material
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Table 1: Summary table showing studies reporting gastrointestinal
involvement of testicular germ cell tumor.
Total 𝑁
Mean age
Range age

25 patients
30.44 years
16–56 years
𝑁 (%)

Type of GCT
Seminoma
NSGCT
Mixed

5 (20%)
15 (60%)
5 (20%)
𝑁 (%)

Range of GI symptoms
Melena
Abdominal pain
Abdominal mass
Hematochezia
Hematemesis
Vomiting, nonbloody
Others (abdominal distension, rigid
abdomen)
Mean hemoglobin at presentation
(g/dl)
EGD done (%)

11/25 (44%)
9/25 (36%)
4/25 (16%)
2/25 (8%)
4/25 (16%)
3/25 (12%)
2/25 (8%)
6.8
21/24 (84%)
𝑁

Laterality of testis involved
Right
Left
Diffuse scrotal swelling
NA
Normal testis on Ultrasound
Testicular symptoms (swelling or
pain) as initial presenting complaint
(%)

14
5
1
3
2
6/25 (24%)

Outcome
Survived 𝑁 (%)
Deaths 𝑁 (%)
Choriocarcinoma
Seminoma
Mixed GCT

Mean follow up (months) 13.2
Survived 15/21 (71%)
Mean days to death 25
Death 6/21 (28%)
4/6 (66%)
1/6 (17%)
1/6 (17%)

GCT: germ cell tumor; NSGCT: non seminomatous germ cell tumor; GI:
gastrointestinal; EGD: esophagogastroduodenoscopy.

available online at https://doi.org/10.1155/2017/4789259).
Mean age was 30.44 years. Sixty percent of patients had
NSGCT with the number increasing to 80% when combined
with mixed GCT which is treated similarly to NSGCT
(Table 1). Prior reviews have demonstrated that NSGCT
are more likely to have GI involvement [20, 21]. The commonest GI manifestations were abdominal pain (46%) and

melena (44%). Other presentation of GI bleeding including
hematemesis and hematochezia accounted for 24% of
initial presentation. Mean hemoglobin was 6.8 g/dl with
patients requiring large volume transfusion to maintain
hemodynamic stability. Other GI presentations including
nonbloody vomiting, abdominal mass, and distension were
less common. Testicular symptoms as an initial presenting
symptom was much less and seen in only 24% of patients.
Six of the 21 patients with follow-up information died,
with a mean time to death of 25 days. Four of deaths
were in patients diagnosed with choriocarcinoma, a more
aggressive GCT associated with extensive metastasis and
varied complication including massive hemorrhage [5, 22].
In conclusion, testicular GCT is a malignancy of the
young. Young men presenting with evidence of GI bleed
with suggestions of underlying malignancy may not offer
information on testicular swelling, even if present. A review
of systems that includes scrotal/testicular swelling should be
conducted and a genital examination done if appropriate.
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